How mild eczema affects parents and caregivers
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This study looks at how caring for a child with mild or moderate eczema (atopic dermatitis) affects you as a caregiver. By sharing your experiences, you can help doctors better understand and support families dealing with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You are a parent or main caregiver of a child aged 2 to 11 with mild or moderate atopic dermatitis (eczema).
- You can read and understand English or French.
- Your child's eczema is not severe.
- Your child is not currently taking oral or topical JAK inhibitor medications.
- Your child is not currently enrolled in another eczema clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an educational video helps caregivers better understand and manage their child's eczema. It may help you feel more confident in caring for your child's skin.
This study looks at tiny skin samples from babies to find clues about eczema. It uses a gentle, painless device that sucks up a small piece of skin. If your baby has eczema or is healthy and under 6 months old, you may be able to join.
This study tests whether a specific diet can help manage mild to moderate eczema. It involves eating whole foods provided by the researchers for a set period and tracking your skin health.
This study looks at how patients with atopic dermatitis (eczema) take part in clinical trials. It aims to understand participation patterns and may help improve future trials.
This study looks at how long people with moderate to severe eczema stay on newer targeted medicines (biologics or pills). By reviewing medical records, researchers hope to learn which treatments work best over time and how they are used in real life.
This study looks at why disease tends to be more severe in some people with atopic dermatitis (eczema), especially those with a specific genetic change in the IL-4 receptor (IL-4Ra). The results may help explain what drives flare-ups and could guide better treatments in the future.
Hear when a new Atopic Dermatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.